Literature DB >> 8585862

Effect of two perfluorocarbon emulsions on reperfusion injury after coronary artery occlusion in rabbits.

S L Hale1, H Hammerman, R A Kloner.   

Abstract

Because of their high oxygen-carrying capability and small particle size, it has been suggested that perfluorochemical emulsions may be useful to reduce reperfusion injury after coronary artery occlusion and reperfusion. We tested the ability of Fluosol and a more concentrated perfluorochemical emulsion (perflubron) to decrease infarct size in anesthetized rabbits undergoing 30 min of coronary occlusion and 4 h of reperfusion. All rabbits were ventilated with 100% oxygen. Treatment was begun at 25 min of coronary occlusion, 5 min before reperfusion. Rabbits were randomized to receive saline (10 ml/kg, n = 15), Fluosol (30 ml/kg, n = 15), or a perflubron emulsion (10 ml/kg, n = 16), or the perflubron emulsion vehicle (10 ml/kg, n = 15). Collateral blood flow during occlusion was measured with radioactive microspheres. The size of the ischemic region at risk was determined by in vivo injection of blue dye and infarct size by in vitro tetrazolium staining. We found that all groups were equally ischemic during occlusion, and that risk zone sizes were comparable. Heart rate and systemic arterial pressure were also similar among groups. Infarct size expressed as a percentage of the risk zone was 30 +/- 4% in saline-treated rabbits, 27 +/- 4% in Fluosol-treated rabbits, and 21 +/- 4% and 21 +/- 3% in perflubron emulsion and perflubron emulsion vehicle treated rabbits, respectively. There was a trend for both perflubron emulsion and perflubron emulsion vehicle groups to have smaller infarcts; however, neither perfluorocarbon emulsion nor the emulsion vehicle significantly reduced infarct size compared with saline treatment. Thus, at the doses used in this study neither Fluosol nor perflubron emulsion, when given just before reperfusion, significantly reduced infarct size in this rabbit model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585862     DOI: 10.1007/bf00788502

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  10 in total

1.  Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA.

Authors:  H E Rice; R Virmani; C L Hart; F D Kolodgie; A Farb
Journal:  Am Heart J       Date:  1990-11       Impact factor: 4.749

2.  Applications of a perfluorocarbon to heart ischemia.

Authors:  P Menasche; M Fauchet; A Lavergne; P Commin; C Masquet; P Birkui; P Lorente; R P Geyer; A Piwnica
Journal:  Prog Clin Biol Res       Date:  1983

3.  Limitations of fluorocarbons in reducing myocardial infarct size.

Authors:  P Menasche; M Escorsin; P Birkui; A Lavergne; M Fauchet; P Commin; P Lorente; R P Geyer; A Piwnica
Journal:  Am J Cardiol       Date:  1985-03-01       Impact factor: 2.778

4.  Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs.

Authors:  G R Nunn; G Dance; J Peters; L H Cohn
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

5.  Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.

Authors:  F D Kolodgie; A Farb; G C Carlson; P S Wilson; R Virmani
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

6.  Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.

Authors:  T C Wall; R M Califf; J Blankenship; J D Talley; M Tannenbaum; M Schwaiger; G Gacioch; M D Cohen; M Sanz; J D Leimberger
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

7.  Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.

Authors:  M B Forman; S Bingham; H A Kopelman; C Wehr; M P Sandler; F Kolodgie; W K Vaughn; G C Friesinger; R Virmani
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

8.  Fluorocarbon and dextran hemodilution in myocardial ischemia.

Authors:  G P Biro
Journal:  Can J Surg       Date:  1983-03       Impact factor: 2.089

9.  Fluorocarbons reduce myocardial ischemic damage after coronary occlusion.

Authors:  D H Glogar; R A Kloner; J Muller; L W DeBoer; E Braunwald; L C Clark
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

10.  Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model.

Authors:  M B Forman; D W Puett; B H Wilson; W K Vaughn; G C Friesinger; R Virmani
Journal:  J Am Coll Cardiol       Date:  1987-05       Impact factor: 24.094

  10 in total
  1 in total

1.  What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?

Authors:  E R Schwarz; Y Somoano; S L Hale; R A Kloner
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.